New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease

BACKGROUND: Glucocorticosteroid is used for patients with primary nephrotic syndrome. This study aims to identify and validate that biomarkers can be used to predict steroid resistance. METHODS: Our study contained two stages, discovery and validation stage. In discovery stage, we enrolled 51 minima...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Proteomics
Autors principals: Weng, Qinjie, Zhou, Qiongxiu, Tong, Jun, Jin, Yuanmeng, Liu, Yunzi, Yu, Xialian, Pan, Xiaoxia, Ren, Hong, Wang, Weiming, Xie, Jingyuan, Chen, Nan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7257237/
https://ncbi.nlm.nih.gov/pubmed/32514258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-020-09282-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars